Kelsey et al. compared the common chemotherapeutic combination of cisplatin and fluorouracil (5-FU) with a paclitaxel-based regimen. Previous studies have shown pathologic complete response rates ...

All patients who experienced a significant paclitaxel HSR were scheduled to rechallenge with docetaxel. All the patients received premedication for the prophylaxis of paclitaxel HSRs. The ...